Charles Eby

Medicine & Life Sciences

1. Warfarin 100%
2. Pharmacogenetics 44%
3. International Normalized Ratio 33%
4. Hemophagocytic Lymphohistiocytosis 32%
5. Hemorrhage 26%
6. Venous Thromboembolism 18%
7. Vitamin K Epoxide Reductases 15%
8. Genotype 14%
9. Cytochrome P-450 Enzyme System 13%
10. Therapeutics 13%
11. Pathologists 13%
12. Thrombosis 12%
13. Hematology 11%
14. Ferritins 11%
15. Cytochrome P-450 CYP2C9 11%
16. Orthopedics 11%
17. Knee Replacement Arthroplasties 11%
18. Autoantibodies 10%
19. Informatics 10%
20. Anticoagulants 10%
21. Vitamin K 10%
22. Venous Thrombosis 9%
23. Blood Platelets 9%
24. Safety 9%
25. Photopheresis 9%
26. Heparin 9%
27. Thoracic Surgery 9%
28. Hip 8%
29. Blood Coagulation Factors 8%
30. Cold Temperature 7%
31. Hemostasis 7%
32. Paraproteinemias 7%
33. Antiphospholipid Syndrome 7%
34. Single Nucleotide Polymorphism 7%
35. von Willebrand Factor 7%
36. Randomized Controlled Trials 6%
37. factor VIII, von Willebrand factor drug combination 6%
38. Thrombin 6%
39. von Willebrand Diseases 6%
40. recombinant FVIIa 6%
41. Transfusion Medicine 6%
42. Serum 6%
43. Practice Guidelines 5%
44. desirudin 5%
45. Ehrlichia 5%
46. Blood Buffy Coat 5%
47. glutamyl carboxylase 5%
48. Vitamin K Deficiency Bleeding 5%
49. Type 3 Von Willebrand's Disease 5%
50. Alleles 5%